SCHEMBL8560485

SCHEMBL8560485

NC/C=C/CN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.56
ALDH1A1 P00352 3/20 0.56
MAPT P10636 3/20 0.56
CYP1A2 P05177 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2D6 P10635 2/20 0.56
CYP2C19 P33261 2/20 0.56
HTR1A P08908 2/20 0.56
TSHR P16473 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
NFKB1 P19838 1/20 0.56
MAPK1 P28482 1/20 0.56
THPO P40225 1/20 0.56
MTOR P42345 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
KDM4E B2RXH2 5/20 0.53
HTR3E A5X5Y0 1/20 0.52
HTR3B O95264 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8560489 1.00 SIGMAR1 (0.56) SIGMAR1ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL1733940 0.82 SIGMAR1 (0.60) SIGMAR1ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL8577276 0.82 SIGMAR1 (0.60) SIGMAR1ALDH1A1MAPTCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL10997933 0.81 SIGMAR1 (0.59) SIGMAR1ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL8561891 0.81 DRD2 (0.56) SIGMAR1HTR1AHTR7
SCHEMBL8567026 0.81 DRD2 (0.56) SIGMAR1HTR1AHTR7
SCHEMBL8561885 0.81 DRD2 (0.56) SIGMAR1HTR1AHTR7
SCHEMBL3457736 0.81 SIGMAR1 (0.69) SIGMAR1ALDH1A1MAPTCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL11280918 0.80 SIGMAR1 (0.67) SIGMAR1ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL3081051 0.80 KCNH2 (0.58) SIGMAR1ALDH1A1MAPTHTR1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5334715-A For treating psychological disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-02 US claimed
EP-0494604-B1 1-Piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-10-07 EP disclosed
US-5440048-A Treating psychoses HOECHST-ROUSSEL PHARMACEUTICALS INC (US) 1995-08-08 US disclosed
US-5334715-A For treating psychological disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-02 US disclosed
US-5194436-A For trating psychosis HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-03-16 US disclosed
EP-0494604-A1 1-Piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-07-15 EP disclosed
US-5130315-A Treatment of psychosis Wittekind, Raymond R. (US) 1992-07-14 US disclosed